These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 12107806

  • 21. Chronic cyclosporine nephrotoxicity: a pig model.
    Cibulskyte D, Kaalund H, Pedersen M, Hørlyck A, Marcussen N, Hansen HE, Madsen M, Mortensen J.
    Transplant Proc; 2005 Oct; 37(8):3298-301. PubMed ID: 16298579
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance.
    Lieberthal W, Fuhro R, Andry C, Patel V, Levine JS.
    Transplantation; 2006 Jul 15; 82(1):17-22. PubMed ID: 16861936
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.
    J Heart Lung Transplant; 2006 Jul 15; 25(7):825-33. PubMed ID: 16818126
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I, du Montcel ST, Jaudon MC, Mallet A, Le Hoang P, Bodaghi B, Deray G, Bagnis CI.
    Nephrol Dial Transplant; 2007 Mar 15; 22(3):880-5. PubMed ID: 17127700
    [Abstract] [Full Text] [Related]

  • 31. Dual response of animals with chronic cyclosporine nephrotoxicity to an acute ischemic injury.
    Campanholle G, Galvão-Pereira M, Cenedeze MA, de Paula A Teixeira V, dos Reis MA, Camara NO, Pacheco-Silva A.
    Transplant Proc; 2006 Dec 15; 38(10):3341-3. PubMed ID: 17175267
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity.
    Yuan J, Zhou J, Chen BC, Zhang X, Zhou HM, Du DF, Chang S, Chen ZK.
    Transplant Proc; 2005 May 15; 37(4):1892-5. PubMed ID: 15919495
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of aldosterone antagonist in experimental nephropathy induced by cyclosporine A.
    Silva FM, Miorin LA, Sens YA.
    Ren Fail; 2008 May 15; 30(4):439-42. PubMed ID: 18569919
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats.
    Louhelainen M, Merasto S, Finckenberg P, Lapatto R, Cheng ZJ, Mervaala EM.
    J Hypertens; 2006 May 15; 24(5):947-56. PubMed ID: 16612258
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.